From: A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer
Characteristics
No. of patients (N = 19)
Age (years)
Median
58
Range
36–65
<60 years
10
≥60 years
9
Gender
Male
16
Female
3
Cigarettes/year
≥400
15
Never smoked
4
Histology
SCC
ADC
UICC stage
IIIA
5
IIIB
14